Gregory Hinkle,Laura Sepp-Lorenzino,Vasant R. Jadhav,Martin A. Maier,Muthiah Manoharan,Stuart Milstein,Svetlana Shulga Morskaya,Kallanthottathil G. Rajeev,Huilei Xu
申请号：
US16801373
公开号：
US20200291405A1
申请日:
2020.02.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the hepatitis D virus (HDV) genome, and methods of using such RNAi agents to inhibit expression of one or more HBV genes and methods of treating subjects having an HDV infection and/or HDV-associated disorder.
